MaxCyte, Inc.’s Post

What are your burning questions and must-discuss topics regarding the digitization of cell therapy manufacturing? Leave a comment below ⬇️

Learn how Vanderbilt University Medical Center saved space, improved efficiency, and minimized the risk associated with their cell therapy manufacturing utilizing a step-wise approach to implementing #automation. https://cytiva.link/0y7gi #digitaltransformation

Learn how Vanderbilt University Medical Center saved space, improved efficiency, and minimized the risk associated with their cell therapy manufacturing utilizing a step-wise approach to implementing #automation. https://cytiva.link/0y7gi #digitaltransformation

🚀 The cell therapy industry is on the brink of a digital revolution… At the recent ISCT conference in Vancouver, Asimov's Head of Process Modelling, Will Johnson, showcased how advanced digital technologies are transforming bioprocess development and vector design. We’ve written up a summary for you, which you can find at https://hubs.ly/Q02Gdr8J0 Here are some of the key takeaways: 1️⃣ Computational modeling and machine learning are being integrated into every step of cell therapy production 2️⃣ Digital tools are enabling end-to-end optimization of viral vector bioprocesses 3️⃣ These advancements are dramatically improving efficiency and outcomes in cell therapy development The future of cell therapy is digital. Are you ready for this transformation? #CellTherapy #DigitalRevolution #Innovation

The digitization of cell manufacturing is set to make these therapies more accessible and affordable! Wondering how? That's why I’m writing a blog. And I'm seeking your invaluable insights! I'm currently crafting a comprehensive article on digitization in cell therapy manufacturing. I want to ensure it covers the latest trends, innovations, and crucial topics. What should I include? Now's your chance to have your voice heard! 👉🏼 Share your burning questions and must-discuss topics in the comments below ⬇️ #celltherapymanufacturing #cgt #cellandgenetherapy

Exciting News! 🚀 Just released our latest #Autologous #Cell #Therapy #Market research report, and the insights are nothing short of game-changing. 🌟 In a rapidly evolving field like regenerative medicine, staying ahead of the curve is essential. Our report delves deep into the current trends, challenges, and opportunities within the autologous cell therapy market. Whether you're a researcher, investor, or industry professional, this is a must-read! 🔍 Key Highlights: ✅ Market Size & Growth Projections ✅ Emerging Therapies & Innovations ✅ Regulatory Updates ✅ Competitive Landscape Get ahead of the competition and make informed decisions. Download the report here: [https://lnkd.in/dBBb4zrK] #CellTherapy #MarketResearch #Innovation #RegenerativeMedicine #HealthcareResearch

Flow cytometry and imaging are two techniques essential to the development of cell therapies - and have the potential for variable data. Read how automation of sample prep can help: https://bit.ly/41WUN0k #DanaherLifeSciences #CART #CellTherapy #flowcytometry #imaging

Working or interested in cell therapy based applications? Then this efficient protocol for processing and cryopreservation of your cell cultures is sure to be a valuable resource. ✨https://lnkd.in/gtnujxht Whether you're working with adherent or suspension cells, this procedure applies to small or large-scale manufacturing. Utilizing cutting-edge tools like the Finia® Fill and Finish System and controlled-rate freezers, the protocol guarantees optimal temperature control and high cell viability. 🌡️ Unleash the potential of your cell therapies – because every breakthrough starts with the right protocol! Work by: Ye Li,Hazel Stevens, Srikanth Sivaraman, PhD, Logan Porter, Allison Hoffman, Stuart Gibb, Ph.D, Shivaram Selvam, and Annie Bowles-Welch, PhD at MC3M (Marcus Center for Cell Characterization and Manufacturing) and Terumo Blood and Cell Technologies. #Biomanufacturing #CellTherapy #research #lifesciences 🧪✨ Have a protocol that can contribute to scientific clarity and reproducibility ? Visit us at https://lnkd.in/dt_igxRi and explore publishing with Bio-protocol! #lifesciences #bio #protocol #bioprotocol #openaccess #reproducibility

The urgent need for better patient access drives the cell therapy field towards automated, closed systems.   So, how can we reduce the manual steps associated with raw materials and improve quality?   We believe that liquid cytokines can contribute to improved sterility and quality, but we want to know what you think; is it suitable for all types of manufacturing and development?   What product formats best fit your current processes during media preparation and integration into the manufacturing unit?   Which raw materials formulation challenges are you facing, and how does that impact manual handling and sterility?   If you’re willing to share your perspective, here’s the link to our survey: https://lnkd.in/gA3RaNmr   We’ll publish the results for you to see how the rest of the industry is tackling these significant challenges.

🌟 Unlocking Potential at the Cellular Level – Discover CellSEP’s Breakthrough in CD34+ Cell Isolation! 🌟 At CellSEP, we're not just following the future; we're creating it! CellSEP is transforming the landscape of medicine by isolating CD34+ cells from cord blood with unprecedented precision and purity. 🔬 Why CD34+ Cells? These powerhouse cells are the cornerstone of hematopoietic stem cell therapies, offering hope and healing for patients with a range of conditions, from leukemia to genetic disorders. The ability of CD34+ cells to renew and transform into various blood cells makes them a beacon of potential in life-saving treatments. 🎯 The CellSEP Edge: Precision and Purity: Our advanced flow cytometry ensures each batch of CD34+ cells meets the highest standards of viability and purity of 98%! Expert Oversight: Each analysis is interpreted by our Ph.D. level SVP of R&D, guaranteeing top-tier quality and reliability. 🤝 Open to Collaboration: We're passionate about pushing the boundaries of what's possible and are eager to collaborate on custom projects for drug development & cell and gene therapy. Whether you're in academia, biotech, or pharma, let's innovate together to harness the full potential of CD34+ cells. Connect with us to explore how our CD34+ cell isolation can revolutionize your projects and ORDER NOW! https://lnkd.in/eJG4a_mD #CellSEP #RegenerativeMedicine #StemCellTherapy #Innovation #CD34Positive #HealthcareTechnology #Biotech #Collaboration #CellandGeneTherapy #Collaborations